| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Consanguinity | 122 | 2024 | 460 | 15.980 |
Why?
|
| Genes, Recessive | 72 | 2024 | 625 | 14.940 |
Why?
|
| Pedigree | 206 | 2024 | 4535 | 13.040 |
Why?
|
| Mutation | 259 | 2024 | 30192 | 11.850 |
Why?
|
| Abnormalities, Multiple | 63 | 2024 | 1424 | 10.830 |
Why?
|
| Homozygote | 103 | 2024 | 1774 | 9.760 |
Why?
|
| Microcephaly | 46 | 2024 | 427 | 9.300 |
Why?
|
| Phenotype | 195 | 2024 | 16714 | 7.370 |
Why?
|
| Saudi Arabia | 61 | 2024 | 211 | 6.330 |
Why?
|
| Dwarfism | 23 | 2022 | 137 | 6.180 |
Why?
|
| Mutation, Missense | 43 | 2024 | 2589 | 4.970 |
Why?
|
| Genetic Predisposition to Disease | 77 | 2024 | 18074 | 4.740 |
Why?
|
| Genetic Association Studies | 50 | 2024 | 2744 | 4.570 |
Why?
|
| Eye Abnormalities | 21 | 2023 | 242 | 4.520 |
Why?
|
| Genetic Heterogeneity | 22 | 2021 | 735 | 4.240 |
Why?
|
| Cilia | 21 | 2024 | 499 | 4.020 |
Why?
|
| Encephalocele | 12 | 2024 | 135 | 3.860 |
Why?
|
| Arthrogryposis | 10 | 2020 | 69 | 3.680 |
Why?
|
| Ichthyosis | 6 | 2023 | 59 | 3.590 |
Why?
|
| Genetic Diseases, Inborn | 12 | 2021 | 606 | 3.560 |
Why?
|
| Limb Deformities, Congenital | 10 | 2019 | 136 | 3.400 |
Why?
|
| Developmental Disabilities | 24 | 2024 | 1519 | 3.380 |
Why?
|
| Cataract | 19 | 2023 | 837 | 3.270 |
Why?
|
| Microphthalmos | 9 | 2024 | 58 | 3.260 |
Why?
|
| Ciliary Motility Disorders | 9 | 2020 | 51 | 3.230 |
Why?
|
| Facies | 25 | 2023 | 223 | 3.230 |
Why?
|
| Alleles | 53 | 2024 | 6891 | 3.170 |
Why?
|
| Membrane Proteins | 35 | 2024 | 7847 | 3.160 |
Why?
|
| Retinitis Pigmentosa | 18 | 2017 | 392 | 3.120 |
Why?
|
| Syndrome | 53 | 2024 | 3271 | 3.050 |
Why?
|
| Child, Preschool | 164 | 2024 | 42510 | 3.030 |
Why?
|
| Sequence Analysis, DNA | 44 | 2024 | 4780 | 3.020 |
Why?
|
| Genome, Human | 28 | 2023 | 4443 | 2.910 |
Why?
|
| DNA Mutational Analysis | 50 | 2019 | 4111 | 2.820 |
Why?
|
| Arabs | 10 | 2023 | 190 | 2.760 |
Why?
|
| Eye Proteins | 14 | 2023 | 628 | 2.740 |
Why?
|
| Child | 209 | 2024 | 80568 | 2.730 |
Why?
|
| RNA, Transfer | 9 | 2022 | 283 | 2.670 |
Why?
|
| Chromosome Mapping | 29 | 2022 | 4617 | 2.600 |
Why?
|
| Coloboma | 7 | 2020 | 60 | 2.560 |
Why?
|
| Retinal Dystrophies | 8 | 2021 | 63 | 2.540 |
Why?
|
| Infertility, Female | 6 | 2022 | 763 | 2.500 |
Why?
|
| Brain Diseases | 11 | 2024 | 1552 | 2.490 |
Why?
|
| Infant | 126 | 2024 | 36426 | 2.430 |
Why?
|
| Base Sequence | 56 | 2022 | 12405 | 2.390 |
Why?
|
| Kidney Diseases, Cystic | 10 | 2020 | 182 | 2.390 |
Why?
|
| Hydrocephalus | 8 | 2022 | 766 | 2.380 |
Why?
|
| Craniofacial Abnormalities | 12 | 2020 | 320 | 2.350 |
Why?
|
| Polycystic Kidney Diseases | 7 | 2017 | 133 | 2.330 |
Why?
|
| Orofaciodigital Syndromes | 5 | 2020 | 21 | 2.320 |
Why?
|
| Ehlers-Danlos Syndrome | 7 | 2018 | 94 | 2.300 |
Why?
|
| Humans | 545 | 2024 | 765926 | 2.280 |
Why?
|
| Genetic Diseases, X-Linked | 9 | 2019 | 386 | 2.260 |
Why?
|
| Male | 348 | 2024 | 363815 | 2.240 |
Why?
|
| Corneal Dystrophies, Hereditary | 5 | 2017 | 62 | 2.190 |
Why?
|
| Ectodermal Dysplasia | 8 | 2023 | 107 | 2.170 |
Why?
|
| Female | 349 | 2024 | 396141 | 2.110 |
Why?
|
| Retinal Detachment | 9 | 2024 | 426 | 2.090 |
Why?
|
| Musculoskeletal Abnormalities | 6 | 2022 | 101 | 2.050 |
Why?
|
| Epilepsy | 22 | 2024 | 3317 | 2.040 |
Why?
|
| Genomics | 23 | 2024 | 5925 | 2.040 |
Why?
|
| Molecular Sequence Data | 51 | 2016 | 17596 | 2.020 |
Why?
|
| Hand Deformities, Congenital | 9 | 2019 | 175 | 2.020 |
Why?
|
| Microtubule-Associated Proteins | 11 | 2020 | 1065 | 2.020 |
Why?
|
| Nerve Tissue Proteins | 15 | 2022 | 4394 | 1.920 |
Why?
|
| Cerebellum | 17 | 2023 | 1519 | 1.920 |
Why?
|
| Amino Acid Sequence | 44 | 2021 | 13398 | 1.900 |
Why?
|
| Hypohidrosis | 4 | 2023 | 29 | 1.880 |
Why?
|
| Genetic Testing | 23 | 2024 | 3594 | 1.870 |
Why?
|
| Bardet-Biedl Syndrome | 5 | 2020 | 51 | 1.870 |
Why?
|
| Cholestasis | 4 | 2024 | 385 | 1.810 |
Why?
|
| Muscle Hypotonia | 8 | 2021 | 166 | 1.810 |
Why?
|
| Nervous System Malformations | 12 | 2023 | 243 | 1.780 |
Why?
|
| Transcription Factors | 26 | 2024 | 12129 | 1.770 |
Why?
|
| Myopia | 7 | 2023 | 254 | 1.750 |
Why?
|
| High-Throughput Nucleotide Sequencing | 23 | 2024 | 3661 | 1.710 |
Why?
|
| Family | 24 | 2022 | 3208 | 1.700 |
Why?
|
| Connective Tissue Diseases | 4 | 2021 | 284 | 1.680 |
Why?
|
| Hydrophthalmos | 5 | 2013 | 24 | 1.670 |
Why?
|
| Skin Abnormalities | 6 | 2016 | 60 | 1.660 |
Why?
|
| Frameshift Mutation | 8 | 2016 | 392 | 1.640 |
Why?
|
| Klippel-Feil Syndrome | 3 | 2020 | 19 | 1.620 |
Why?
|
| Mitochondrial Proteins | 10 | 2022 | 975 | 1.610 |
Why?
|
| Iris | 5 | 2016 | 232 | 1.610 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 6 | 2020 | 298 | 1.560 |
Why?
|
| Genetic Loci | 13 | 2020 | 2630 | 1.550 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 11 | 2023 | 2879 | 1.540 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 5 | 2013 | 246 | 1.540 |
Why?
|
| Centrioles | 6 | 2023 | 80 | 1.510 |
Why?
|
| Genetic Variation | 19 | 2023 | 6612 | 1.510 |
Why?
|
| Genetic Markers | 8 | 2021 | 2603 | 1.500 |
Why?
|
| ADAM Proteins | 7 | 2022 | 243 | 1.490 |
Why?
|
| Syndactyly | 3 | 2018 | 75 | 1.480 |
Why?
|
| Carrier Proteins | 12 | 2021 | 4909 | 1.470 |
Why?
|
| Adolescent | 127 | 2024 | 88811 | 1.470 |
Why?
|
| Osteochondrodysplasias | 4 | 2020 | 183 | 1.460 |
Why?
|
| Spasms, Infantile | 8 | 2020 | 300 | 1.460 |
Why?
|
| Eye Diseases, Hereditary | 5 | 2023 | 124 | 1.450 |
Why?
|
| Myopia, Degenerative | 4 | 2015 | 13 | 1.440 |
Why?
|
| Guanine Nucleotide Exchange Factors | 11 | 2024 | 571 | 1.430 |
Why?
|
| Oocytes | 4 | 2022 | 1168 | 1.430 |
Why?
|
| Retina | 18 | 2023 | 2648 | 1.430 |
Why?
|
| Genotype | 38 | 2023 | 13026 | 1.400 |
Why?
|
| Disease | 4 | 2022 | 674 | 1.390 |
Why?
|
| Arachnodactyly | 3 | 2021 | 10 | 1.350 |
Why?
|
| T-Box Domain Proteins | 3 | 2019 | 469 | 1.350 |
Why?
|
| Proteins | 16 | 2024 | 5994 | 1.350 |
Why?
|
| Blepharophimosis | 3 | 2021 | 21 | 1.340 |
Why?
|
| tRNA Methyltransferases | 6 | 2022 | 50 | 1.340 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2022 | 833 | 1.330 |
Why?
|
| Population Groups | 2 | 2021 | 209 | 1.320 |
Why?
|
| Mosaicism | 3 | 2021 | 481 | 1.310 |
Why?
|
| Myopathies, Nemaline | 3 | 2020 | 73 | 1.310 |
Why?
|
| Scalp Dermatoses | 4 | 2016 | 44 | 1.310 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 4 | 2021 | 17 | 1.300 |
Why?
|
| Abortion, Habitual | 3 | 2020 | 65 | 1.300 |
Why?
|
| Codon, Nonsense | 7 | 2017 | 288 | 1.290 |
Why?
|
| Contracture | 4 | 2024 | 235 | 1.290 |
Why?
|
| Osteogenesis Imperfecta | 4 | 2015 | 81 | 1.260 |
Why?
|
| Bone Diseases, Developmental | 5 | 2023 | 131 | 1.260 |
Why?
|
| Infant, Newborn | 54 | 2024 | 26380 | 1.250 |
Why?
|
| DNA-Binding Proteins | 19 | 2023 | 9600 | 1.240 |
Why?
|
| Corneal Diseases | 5 | 2013 | 535 | 1.240 |
Why?
|
| Genetic Linkage | 19 | 2020 | 2342 | 1.230 |
Why?
|
| Corneal Opacity | 3 | 2013 | 52 | 1.210 |
Why?
|
| Lissencephaly | 4 | 2021 | 36 | 1.210 |
Why?
|
| Muscle Spasticity | 3 | 2017 | 159 | 1.200 |
Why?
|
| Autopsy | 4 | 2021 | 1011 | 1.190 |
Why?
|
| Aniridia | 3 | 2013 | 36 | 1.160 |
Why?
|
| Ectopia Lentis | 5 | 2014 | 20 | 1.140 |
Why?
|
| Polydactyly | 3 | 2017 | 57 | 1.130 |
Why?
|
| Zebrafish | 26 | 2024 | 3035 | 1.130 |
Why?
|
| Point Mutation | 7 | 2020 | 1590 | 1.110 |
Why?
|
| Homeodomain Proteins | 9 | 2017 | 2430 | 1.100 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2023 | 2795 | 1.100 |
Why?
|
| Leukoencephalopathies | 3 | 2017 | 259 | 1.100 |
Why?
|
| Infertility, Male | 4 | 2020 | 395 | 1.090 |
Why?
|
| Polymorphism, Single Nucleotide | 35 | 2023 | 16039 | 1.090 |
Why?
|
| Mitochondrial Diseases | 5 | 2021 | 344 | 1.090 |
Why?
|
| Mitochondrial Myopathies | 2 | 2018 | 49 | 1.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 11 | 2023 | 2897 | 1.080 |
Why?
|
| Cerebellar Diseases | 6 | 2019 | 227 | 1.080 |
Why?
|
| Rhabdomyolysis | 2 | 2021 | 150 | 1.070 |
Why?
|
| Myosins | 2 | 2020 | 408 | 1.060 |
Why?
|
| Acidosis, Lactic | 3 | 2018 | 144 | 1.050 |
Why?
|
| Repressor Proteins | 12 | 2024 | 2969 | 1.050 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2018 | 182 | 1.040 |
Why?
|
| Proto-Oncogene Proteins c-abl | 2 | 2024 | 145 | 1.040 |
Why?
|
| Founder Effect | 7 | 2024 | 185 | 1.030 |
Why?
|
| Wnt Proteins | 4 | 2024 | 722 | 1.030 |
Why?
|
| Cell Cycle Proteins | 12 | 2022 | 3431 | 1.020 |
Why?
|
| Haplotypes | 11 | 2021 | 2726 | 1.020 |
Why?
|
| Nuclear Proteins | 12 | 2023 | 5782 | 1.010 |
Why?
|
| Peroxisomal Disorders | 2 | 2018 | 12 | 1.010 |
Why?
|
| Sequence Deletion | 6 | 2013 | 1494 | 1.000 |
Why?
|
| Databases, Genetic | 8 | 2023 | 1756 | 1.000 |
Why?
|
| Cytoskeletal Proteins | 11 | 2022 | 1322 | 0.990 |
Why?
|
| N-Acetylglucosaminyltransferases | 5 | 2017 | 168 | 0.980 |
Why?
|
| Vesicular Transport Proteins | 4 | 2024 | 376 | 0.980 |
Why?
|
| Sodium Channels | 3 | 2020 | 337 | 0.980 |
Why?
|
| Phosphoglycerate Dehydrogenase | 2 | 2016 | 38 | 0.970 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 2 | 2019 | 207 | 0.970 |
Why?
|
| Golgi Apparatus | 3 | 2020 | 405 | 0.960 |
Why?
|
| Epilepsy, Generalized | 4 | 2023 | 182 | 0.950 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2021 | 235 | 0.950 |
Why?
|
| Mitochondrial Encephalomyopathies | 4 | 2018 | 40 | 0.940 |
Why?
|
| Animals | 108 | 2024 | 168735 | 0.940 |
Why?
|
| Young Adult | 73 | 2024 | 59857 | 0.940 |
Why?
|
| Heterozygote | 15 | 2021 | 2796 | 0.940 |
Why?
|
| Genetics, Medical | 2 | 2021 | 334 | 0.940 |
Why?
|
| Adenosine Deaminase | 3 | 2019 | 253 | 0.940 |
Why?
|
| Hirschsprung Disease | 2 | 2022 | 164 | 0.930 |
Why?
|
| Neural Tube Defects | 2 | 2018 | 256 | 0.920 |
Why?
|
| Psychomotor Disorders | 3 | 2020 | 149 | 0.920 |
Why?
|
| Lens Subluxation | 2 | 2014 | 23 | 0.910 |
Why?
|
| Congenital Abnormalities | 6 | 2023 | 704 | 0.900 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2024 | 75 | 0.890 |
Why?
|
| Face | 9 | 2022 | 1029 | 0.890 |
Why?
|
| Exons | 14 | 2021 | 2393 | 0.890 |
Why?
|
| Ion Channels | 3 | 2020 | 1044 | 0.890 |
Why?
|
| Hearing Loss, Sensorineural | 7 | 2021 | 781 | 0.880 |
Why?
|
| Atrophy | 9 | 2023 | 1629 | 0.880 |
Why?
|
| Seizures | 10 | 2023 | 2997 | 0.870 |
Why?
|
| Dandy-Walker Syndrome | 3 | 2020 | 44 | 0.870 |
Why?
|
| Cornea | 6 | 2017 | 1315 | 0.870 |
Why?
|
| Retinal Cone Photoreceptor Cells | 3 | 2021 | 184 | 0.870 |
Why?
|
| Glaucoma | 6 | 2018 | 1192 | 0.860 |
Why?
|
| Mice | 62 | 2024 | 81782 | 0.860 |
Why?
|
| Megacolon | 1 | 2022 | 11 | 0.850 |
Why?
|
| Cleft Palate | 6 | 2020 | 596 | 0.830 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2024 | 129 | 0.830 |
Why?
|
| Strabismus | 4 | 2016 | 320 | 0.820 |
Why?
|
| Basal Ganglia Diseases | 4 | 2019 | 145 | 0.820 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2022 | 19 | 0.820 |
Why?
|
| Genome-Wide Association Study | 19 | 2023 | 12803 | 0.810 |
Why?
|
| Latent TGF-beta Binding Proteins | 4 | 2021 | 45 | 0.810 |
Why?
|
| Genetics, Population | 4 | 2021 | 943 | 0.810 |
Why?
|
| Cadherins | 3 | 2021 | 899 | 0.810 |
Why?
|
| Sequence Alignment | 10 | 2020 | 2172 | 0.800 |
Why?
|
| Inheritance Patterns | 2 | 2024 | 345 | 0.800 |
Why?
|
| Foot Deformities, Congenital | 2 | 2012 | 59 | 0.800 |
Why?
|
| Sodium-Bicarbonate Symporters | 2 | 2023 | 30 | 0.800 |
Why?
|
| Molecular Sequence Annotation | 5 | 2021 | 525 | 0.780 |
Why?
|
| Fetal Growth Retardation | 3 | 2016 | 591 | 0.780 |
Why?
|
| Metalloendopeptidases | 2 | 2014 | 386 | 0.780 |
Why?
|
| Fatal Outcome | 10 | 2018 | 1835 | 0.770 |
Why?
|
| Adult | 103 | 2024 | 223088 | 0.770 |
Why?
|
| Disorders of Sex Development | 2 | 2020 | 129 | 0.770 |
Why?
|
| Pseudouridine | 2 | 2019 | 19 | 0.770 |
Why?
|
| Optic Atrophy | 3 | 2017 | 78 | 0.770 |
Why?
|
| Metalloproteases | 1 | 2021 | 61 | 0.760 |
Why?
|
| gamma-Crystallins | 2 | 2012 | 9 | 0.760 |
Why?
|
| Methyltransferases | 3 | 2023 | 372 | 0.750 |
Why?
|
| Genetic Counseling | 3 | 2021 | 634 | 0.750 |
Why?
|
| Cafe-au-Lait Spots | 1 | 2021 | 20 | 0.750 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2021 | 85 | 0.750 |
Why?
|
| Bone and Bones | 5 | 2020 | 2555 | 0.740 |
Why?
|
| Amino Acid Substitution | 6 | 2020 | 1740 | 0.740 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2021 | 24 | 0.740 |
Why?
|
| Visual Acuity | 13 | 2024 | 2670 | 0.740 |
Why?
|
| Serine | 2 | 2016 | 825 | 0.740 |
Why?
|
| Hoarseness | 1 | 2021 | 63 | 0.730 |
Why?
|
| Genes, Lethal | 3 | 2017 | 224 | 0.730 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 2019 | 165 | 0.720 |
Why?
|
| Ear | 2 | 2020 | 172 | 0.720 |
Why?
|
| Calcium-Binding Proteins | 4 | 2021 | 1077 | 0.720 |
Why?
|
| Stiff-Person Syndrome | 2 | 2022 | 32 | 0.720 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2022 | 51 | 0.720 |
Why?
|
| Polyhydramnios | 1 | 2020 | 41 | 0.720 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2022 | 765 | 0.710 |
Why?
|
| Muscle Proteins | 3 | 2016 | 1160 | 0.710 |
Why?
|
| Cleft Lip | 5 | 2017 | 512 | 0.710 |
Why?
|
| Gene Deletion | 6 | 2020 | 2667 | 0.710 |
Why?
|
| Mitochondria | 8 | 2024 | 3669 | 0.710 |
Why?
|
| Chromosomes, Human, Pair 2 | 5 | 2012 | 313 | 0.710 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2021 | 698 | 0.700 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2020 | 3 | 0.700 |
Why?
|
| Hypoventilation | 1 | 2020 | 44 | 0.700 |
Why?
|
| Oligospermia | 1 | 2020 | 61 | 0.700 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2020 | 26 | 0.690 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 48 | 0.690 |
Why?
|
| Claudins | 2 | 2018 | 118 | 0.690 |
Why?
|
| Horses | 1 | 2021 | 294 | 0.690 |
Why?
|
| Death, Sudden | 2 | 2021 | 301 | 0.680 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2019 | 13 | 0.680 |
Why?
|
| Tolloid-Like Metalloproteinases | 1 | 2019 | 7 | 0.680 |
Why?
|
| Serine Endopeptidases | 3 | 2023 | 1024 | 0.680 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2019 | 22 | 0.670 |
Why?
|
| Muscular Atrophy | 2 | 2013 | 335 | 0.670 |
Why?
|
| Malates | 1 | 2019 | 35 | 0.670 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2021 | 614 | 0.670 |
Why?
|
| Malate Dehydrogenase | 1 | 2019 | 40 | 0.660 |
Why?
|
| Neurofibromin 1 | 1 | 2021 | 190 | 0.660 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2011 | 199 | 0.660 |
Why?
|
| Encephalitis | 1 | 2023 | 440 | 0.660 |
Why?
|
| Actins | 4 | 2021 | 2057 | 0.650 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2024 | 102 | 0.640 |
Why?
|
| Carboxypeptidases | 2 | 2018 | 121 | 0.640 |
Why?
|
| Liver Diseases | 2 | 2018 | 1304 | 0.640 |
Why?
|
| Arthritis | 3 | 2021 | 676 | 0.640 |
Why?
|
| Protein Conformation | 11 | 2021 | 3945 | 0.630 |
Why?
|
| Biological Specimen Banks | 3 | 2023 | 787 | 0.630 |
Why?
|
| Uridine | 1 | 2019 | 135 | 0.630 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2019 | 114 | 0.630 |
Why?
|
| Fetal Proteins | 2 | 2018 | 99 | 0.630 |
Why?
|
| Mice, Knockout | 21 | 2024 | 14450 | 0.620 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2019 | 164 | 0.620 |
Why?
|
| Alopecia | 4 | 2019 | 415 | 0.620 |
Why?
|
| Walker-Warburg Syndrome | 2 | 2020 | 15 | 0.620 |
Why?
|
| Fibroblasts | 18 | 2023 | 4161 | 0.620 |
Why?
|
| Dysphonia | 1 | 2021 | 144 | 0.620 |
Why?
|
| Wolf-Hirschhorn Syndrome | 1 | 2018 | 5 | 0.620 |
Why?
|
| Ubiquitin-Protein Ligases | 8 | 2024 | 1894 | 0.620 |
Why?
|
| DNA | 10 | 2021 | 7193 | 0.610 |
Why?
|
| Nucleotide Transport Proteins | 1 | 2018 | 5 | 0.610 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2018 | 118 | 0.610 |
Why?
|
| Anus, Imperforate | 2 | 2016 | 63 | 0.610 |
Why?
|
| Collagen Type XI | 2 | 2021 | 21 | 0.600 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2019 | 452 | 0.600 |
Why?
|
| Eye | 5 | 2021 | 709 | 0.600 |
Why?
|
| Gene Knockout Techniques | 4 | 2016 | 798 | 0.600 |
Why?
|
| GTP-Binding Proteins | 4 | 2023 | 944 | 0.600 |
Why?
|
| Collagen Type V | 1 | 2017 | 16 | 0.600 |
Why?
|
| Ear Diseases | 1 | 2020 | 179 | 0.600 |
Why?
|
| Skin Diseases, Genetic | 2 | 2021 | 49 | 0.600 |
Why?
|
| Muscular Diseases | 3 | 2024 | 551 | 0.590 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 239 | 0.590 |
Why?
|
| Ulna | 1 | 2019 | 133 | 0.590 |
Why?
|
| Branchial Region | 1 | 2017 | 36 | 0.590 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2021 | 392 | 0.590 |
Why?
|
| Models, Molecular | 11 | 2021 | 5377 | 0.590 |
Why?
|
| Glucosyltransferases | 1 | 2018 | 94 | 0.590 |
Why?
|
| Pregnancy | 25 | 2024 | 30230 | 0.590 |
Why?
|
| Quantitative Trait Loci | 3 | 2015 | 2136 | 0.580 |
Why?
|
| Cutis Laxa | 2 | 2021 | 29 | 0.580 |
Why?
|
| Lod Score | 6 | 2015 | 599 | 0.580 |
Why?
|
| Peroxisomes | 3 | 2016 | 63 | 0.580 |
Why?
|
| Voice Disorders | 1 | 2021 | 286 | 0.580 |
Why?
|
| RNA Helicases | 2 | 2020 | 144 | 0.570 |
Why?
|
| Mucopolysaccharidosis IV | 2 | 2014 | 7 | 0.570 |
Why?
|
| Phosphate Transport Proteins | 1 | 2017 | 12 | 0.570 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 196 | 0.570 |
Why?
|
| Heart Defects, Congenital | 7 | 2024 | 4712 | 0.560 |
Why?
|
| Lens, Crystalline | 4 | 2012 | 387 | 0.560 |
Why?
|
| Congenital Hypothyroidism | 2 | 2018 | 40 | 0.560 |
Why?
|
| Codon | 1 | 2019 | 599 | 0.560 |
Why?
|
| Genitalia | 1 | 2017 | 114 | 0.560 |
Why?
|
| RNA-Binding Proteins | 5 | 2022 | 1882 | 0.560 |
Why?
|
| Acyltransferases | 1 | 2019 | 305 | 0.560 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2016 | 11 | 0.560 |
Why?
|
| Macula Lutea | 1 | 2018 | 168 | 0.560 |
Why?
|
| Blepharoptosis | 3 | 2015 | 144 | 0.560 |
Why?
|
| Aspartic Acid | 1 | 2019 | 575 | 0.550 |
Why?
|
| Polymerase Chain Reaction | 14 | 2021 | 6058 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2010 | 417 | 0.550 |
Why?
|
| Embryonic Development | 5 | 2016 | 719 | 0.550 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2016 | 16 | 0.550 |
Why?
|
| Hypogonadism | 4 | 2019 | 801 | 0.550 |
Why?
|
| Ribonucleases | 1 | 2017 | 265 | 0.550 |
Why?
|
| Gene Frequency | 3 | 2020 | 3623 | 0.540 |
Why?
|
| Wnt1 Protein | 2 | 2015 | 120 | 0.540 |
Why?
|
| Retinal Degeneration | 5 | 2024 | 413 | 0.540 |
Why?
|
| Genes, Dominant | 2 | 2017 | 855 | 0.540 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2016 | 21 | 0.540 |
Why?
|
| Severity of Illness Index | 8 | 2020 | 15878 | 0.540 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 2 | 2014 | 32 | 0.530 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2017 | 74 | 0.530 |
Why?
|
| GA-Binding Protein Transcription Factor | 2 | 2014 | 43 | 0.530 |
Why?
|
| Casein Kinase I | 2 | 2020 | 46 | 0.530 |
Why?
|
| Acro-Osteolysis | 1 | 2016 | 3 | 0.520 |
Why?
|
| Ribonucleoproteins | 3 | 2016 | 359 | 0.520 |
Why?
|
| Cohort Studies | 27 | 2021 | 41680 | 0.520 |
Why?
|
| alpha-Crystallin B Chain | 3 | 2013 | 23 | 0.520 |
Why?
|
| Pyroglutamate Hydrolase | 2 | 2016 | 3 | 0.520 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2023 | 887 | 0.520 |
Why?
|
| Adenine Nucleotide Translocator 1 | 1 | 2015 | 4 | 0.520 |
Why?
|
| Hydro-Lyases | 1 | 2016 | 93 | 0.520 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 498 | 0.520 |
Why?
|
| Twins, Monozygotic | 1 | 2018 | 470 | 0.520 |
Why?
|
| Zygote | 1 | 2016 | 117 | 0.520 |
Why?
|
| Retinal Artery | 2 | 2019 | 108 | 0.520 |
Why?
|
| Protein Subunits | 1 | 2019 | 939 | 0.520 |
Why?
|
| Keratinocytes | 2 | 2020 | 861 | 0.510 |
Why?
|
| Metabolic Diseases | 2 | 2019 | 686 | 0.510 |
Why?
|
| Tooth Abnormalities | 3 | 2023 | 56 | 0.510 |
Why?
|
| Ellis-Van Creveld Syndrome | 2 | 2015 | 8 | 0.510 |
Why?
|
| beta-Crystallin B Chain | 2 | 2012 | 2 | 0.500 |
Why?
|
| Autoantigens | 2 | 2020 | 886 | 0.500 |
Why?
|
| Muscular Dystrophies | 2 | 2016 | 392 | 0.500 |
Why?
|
| Breast Diseases | 1 | 2019 | 436 | 0.500 |
Why?
|
| Trisomy | 3 | 2006 | 260 | 0.500 |
Why?
|
| Chromosome Deletion | 6 | 2023 | 1384 | 0.500 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2016 | 246 | 0.490 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2024 | 415 | 0.490 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 2016 | 149 | 0.490 |
Why?
|
| Movement Disorders | 3 | 2024 | 460 | 0.490 |
Why?
|
| Immunoglobulins | 1 | 2018 | 853 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2013 | 310 | 0.490 |
Why?
|
| Nervous System Diseases | 4 | 2020 | 1657 | 0.490 |
Why?
|
| Computational Biology | 5 | 2019 | 3562 | 0.490 |
Why?
|
| GTPase-Activating Proteins | 2 | 2020 | 465 | 0.490 |
Why?
|
| Receptors, Cell Surface | 3 | 2021 | 2814 | 0.490 |
Why?
|
| Zebrafish Proteins | 6 | 2020 | 1017 | 0.490 |
Why?
|
| Transaminases | 1 | 2016 | 199 | 0.490 |
Why?
|
| Centrosome | 2 | 2013 | 209 | 0.480 |
Why?
|
| Potassium Channels | 1 | 2018 | 534 | 0.480 |
Why?
|
| Infertility | 1 | 2022 | 655 | 0.480 |
Why?
|
| 3' Untranslated Regions | 1 | 2017 | 514 | 0.480 |
Why?
|
| Meningocele | 1 | 2015 | 50 | 0.480 |
Why?
|
| Joint Instability | 5 | 2024 | 802 | 0.480 |
Why?
|
| Membrane Transport Proteins | 4 | 2024 | 1028 | 0.480 |
Why?
|
| Brain | 27 | 2024 | 27179 | 0.480 |
Why?
|
| Hedgehog Proteins | 6 | 2023 | 772 | 0.480 |
Why?
|
| Telangiectasis | 1 | 2015 | 77 | 0.480 |
Why?
|
| Gene Rearrangement | 6 | 2024 | 1143 | 0.480 |
Why?
|
| Endodeoxyribonucleases | 2 | 2016 | 165 | 0.480 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 1086 | 0.470 |
Why?
|
| DNA Damage | 5 | 2021 | 2462 | 0.470 |
Why?
|
| Skin Diseases, Vascular | 1 | 2015 | 41 | 0.470 |
Why?
|
| Karyotyping | 6 | 2016 | 1175 | 0.470 |
Why?
|
| Peptic Ulcer | 1 | 2016 | 214 | 0.470 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2016 | 1621 | 0.470 |
Why?
|
| Lamin Type A | 1 | 2016 | 186 | 0.470 |
Why?
|
| Endonucleases | 2 | 2016 | 372 | 0.470 |
Why?
|
| CHARGE Syndrome | 1 | 2014 | 34 | 0.470 |
Why?
|
| Neuropilin-1 | 1 | 2015 | 90 | 0.470 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2014 | 81 | 0.470 |
Why?
|
| Fingers | 2 | 2019 | 509 | 0.470 |
Why?
|
| Receptors, AMPA | 1 | 2016 | 335 | 0.470 |
Why?
|
| Spastic Paraplegia, Hereditary | 2 | 2021 | 171 | 0.470 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2015 | 63 | 0.470 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2020 | 1657 | 0.460 |
Why?
|
| Joint Diseases | 2 | 2016 | 459 | 0.460 |
Why?
|
| Mucociliary Clearance | 3 | 2021 | 81 | 0.460 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 587 | 0.460 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 1348 | 0.460 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2014 | 23 | 0.460 |
Why?
|
| Amino Acid Transport Systems, Neutral | 2 | 2015 | 42 | 0.460 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 506 | 0.450 |
Why?
|
| Pellagra | 1 | 2013 | 7 | 0.450 |
Why?
|
| Intermediate Filament Proteins | 2 | 2012 | 261 | 0.450 |
Why?
|
| Umbilicus | 1 | 2014 | 38 | 0.450 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2015 | 169 | 0.450 |
Why?
|
| Cockayne Syndrome | 1 | 2013 | 20 | 0.450 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2013 | 31 | 0.450 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2014 | 98 | 0.450 |
Why?
|
| Cranial Nerves | 1 | 2014 | 97 | 0.450 |
Why?
|
| Mixed Function Oxygenases | 2 | 2017 | 265 | 0.450 |
Why?
|
| Anion Transport Proteins | 2 | 2018 | 141 | 0.440 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2013 | 70 | 0.440 |
Why?
|
| Calcium Channels | 1 | 2017 | 622 | 0.440 |
Why?
|
| Cathepsin H | 1 | 2013 | 10 | 0.440 |
Why?
|
| Duane Retraction Syndrome | 1 | 2014 | 59 | 0.440 |
Why?
|
| Blepharospasm | 1 | 2013 | 34 | 0.440 |
Why?
|
| Leber Congenital Amaurosis | 2 | 2013 | 36 | 0.440 |
Why?
|
| Exotropia | 1 | 2014 | 64 | 0.440 |
Why?
|
| DNA Copy Number Variations | 5 | 2019 | 2045 | 0.430 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2015 | 141 | 0.430 |
Why?
|
| Consensus Sequence | 2 | 2012 | 363 | 0.430 |
Why?
|
| Conserved Sequence | 5 | 2021 | 1159 | 0.430 |
Why?
|
| Gene Expression Regulation | 14 | 2021 | 11895 | 0.430 |
Why?
|
| Serine Proteases | 2 | 2013 | 43 | 0.430 |
Why?
|
| Cogan Syndrome | 1 | 2013 | 10 | 0.430 |
Why?
|
| Collagen Type XVIII | 1 | 2013 | 52 | 0.430 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2013 | 120 | 0.430 |
Why?
|
| Fanconi Anemia | 2 | 2016 | 327 | 0.430 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 3 | 2016 | 284 | 0.430 |
Why?
|
| Vestibular Diseases | 2 | 2022 | 232 | 0.430 |
Why?
|
| Transaldolase | 1 | 2013 | 10 | 0.430 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2013 | 9 | 0.420 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2012 | 16 | 0.420 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2013 | 88 | 0.420 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2014 | 144 | 0.420 |
Why?
|
| Anterior Eye Segment | 1 | 2014 | 144 | 0.420 |
Why?
|
| Gonads | 1 | 2013 | 110 | 0.420 |
Why?
|
| Antiporters | 2 | 2017 | 275 | 0.420 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2013 | 86 | 0.420 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2012 | 17 | 0.420 |
Why?
|
| Electroretinography | 7 | 2015 | 524 | 0.420 |
Why?
|
| Prader-Willi Syndrome | 1 | 2014 | 80 | 0.420 |
Why?
|
| Ectromelia | 1 | 2012 | 28 | 0.420 |
Why?
|
| Niacin | 1 | 2013 | 116 | 0.420 |
Why?
|
| Acetylesterase | 1 | 2012 | 14 | 0.410 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2013 | 46 | 0.410 |
Why?
|
| Posterior Eye Segment | 1 | 2012 | 18 | 0.410 |
Why?
|
| Ossification, Heterotopic | 1 | 2015 | 239 | 0.410 |
Why?
|
| Dystonia | 3 | 2024 | 378 | 0.410 |
Why?
|
| Urogenital Abnormalities | 4 | 2022 | 255 | 0.410 |
Why?
|
| Growth Disorders | 4 | 2024 | 633 | 0.410 |
Why?
|
| Prenatal Diagnosis | 5 | 2020 | 1271 | 0.410 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2014 | 197 | 0.400 |
Why?
|
| Abdomen | 1 | 2018 | 1135 | 0.400 |
Why?
|
| Weill-Marchesani Syndrome | 1 | 2012 | 6 | 0.400 |
Why?
|
| Spine | 3 | 2015 | 1132 | 0.400 |
Why?
|
| Night Blindness | 1 | 2012 | 58 | 0.400 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2036 | 0.400 |
Why?
|
| Hemizygote | 1 | 2012 | 27 | 0.400 |
Why?
|
| Nose | 5 | 2024 | 518 | 0.390 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2012 | 8 | 0.390 |
Why?
|
| Hematologic Diseases | 2 | 2022 | 500 | 0.390 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2012 | 83 | 0.390 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2019 | 2255 | 0.390 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2012 | 72 | 0.390 |
Why?
|
| Rare Diseases | 4 | 2021 | 629 | 0.390 |
Why?
|
| General Practice | 1 | 2013 | 101 | 0.380 |
Why?
|
| Neuromuscular Junction | 1 | 2014 | 399 | 0.380 |
Why?
|
| Body Patterning | 2 | 2016 | 633 | 0.380 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2011 | 1 | 0.380 |
Why?
|
| beta-Hexosaminidase beta Chain | 1 | 2011 | 1 | 0.380 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2020 | 2743 | 0.380 |
Why?
|
| Optic Nerve Diseases | 1 | 2015 | 342 | 0.380 |
Why?
|
| Intraocular Pressure | 5 | 2018 | 1302 | 0.380 |
Why?
|
| Vitiligo | 1 | 2012 | 96 | 0.370 |
Why?
|
| Embryo, Mammalian | 7 | 2015 | 1674 | 0.370 |
Why?
|
| Blindness | 3 | 2012 | 587 | 0.370 |
Why?
|
| Quadriplegia | 2 | 2017 | 227 | 0.370 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2011 | 20 | 0.370 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 790 | 0.370 |
Why?
|
| Marfan Syndrome | 1 | 2013 | 237 | 0.370 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2011 | 22 | 0.370 |
Why?
|
| Pancreas | 2 | 2023 | 1698 | 0.360 |
Why?
|
| Siblings | 5 | 2017 | 828 | 0.360 |
Why?
|
| Gene Order | 4 | 2015 | 164 | 0.360 |
Why?
|
| Sinusitis | 1 | 2020 | 995 | 0.360 |
Why?
|
| Radiography | 9 | 2019 | 6941 | 0.360 |
Why?
|
| Endothelin-3 | 1 | 2010 | 9 | 0.360 |
Why?
|
| Trans-Activators | 3 | 2020 | 2848 | 0.360 |
Why?
|
| Scleral Diseases | 1 | 2010 | 22 | 0.360 |
Why?
|
| Fetal Death | 1 | 2012 | 434 | 0.350 |
Why?
|
| Nucleotidases | 1 | 2010 | 28 | 0.350 |
Why?
|
| Malformations of Cortical Development | 1 | 2012 | 174 | 0.350 |
Why?
|
| Langer-Giedion Syndrome | 1 | 2010 | 5 | 0.350 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2012 | 246 | 0.350 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2016 | 1164 | 0.350 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 519 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2024 | 36547 | 0.350 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2010 | 25 | 0.340 |
Why?
|
| Protein Kinase C | 1 | 2015 | 1202 | 0.340 |
Why?
|
| Sequence Analysis | 1 | 2011 | 239 | 0.340 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 5 | 2018 | 169 | 0.340 |
Why?
|
| Transcription Factor AP-2 | 1 | 2010 | 78 | 0.340 |
Why?
|
| Haploinsufficiency | 3 | 2024 | 334 | 0.340 |
Why?
|
| Kidney Diseases | 2 | 2022 | 2100 | 0.340 |
Why?
|
| Kidney | 6 | 2022 | 7073 | 0.340 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2011 | 205 | 0.340 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2016 | 4520 | 0.340 |
Why?
|
| Hypoglycemia | 2 | 2015 | 896 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 348 | 0.340 |
Why?
|
| Anophthalmos | 2 | 2024 | 23 | 0.330 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2010 | 63 | 0.330 |
Why?
|
| Open Reading Frames | 3 | 2010 | 820 | 0.330 |
Why?
|
| Cystinosis | 1 | 2009 | 26 | 0.330 |
Why?
|
| Adrenoleukodystrophy | 1 | 2012 | 145 | 0.330 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 433 | 0.330 |
Why?
|
| Zellweger Syndrome | 1 | 2009 | 8 | 0.330 |
Why?
|
| Middle East | 4 | 2021 | 237 | 0.330 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2010 | 50 | 0.330 |
Why?
|
| Phosphoproteins | 2 | 2016 | 2444 | 0.320 |
Why?
|
| Transforming Growth Factor beta | 2 | 2017 | 1996 | 0.320 |
Why?
|
| Optic Disk | 1 | 2013 | 419 | 0.320 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2010 | 87 | 0.320 |
Why?
|
| Amenorrhea | 1 | 2012 | 470 | 0.320 |
Why?
|
| Ocular Motility Disorders | 1 | 2010 | 144 | 0.320 |
Why?
|
| Armadillo Domain Proteins | 2 | 2020 | 25 | 0.320 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2021 | 335 | 0.320 |
Why?
|
| Chromosome Breakage | 3 | 2018 | 159 | 0.310 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 454 | 0.310 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 613 | 0.310 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2014 | 2430 | 0.310 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2022 | 156 | 0.310 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2021 | 309 | 0.310 |
Why?
|
| RNA, Messenger | 9 | 2024 | 12768 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 634 | 0.310 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 18292 | 0.310 |
Why?
|
| Neoplasm Proteins | 5 | 2021 | 3592 | 0.310 |
Why?
|
| Qa-SNARE Proteins | 2 | 2021 | 51 | 0.300 |
Why?
|
| Pneumonia | 1 | 2020 | 2158 | 0.300 |
Why?
|
| Neutropenia | 1 | 2013 | 894 | 0.300 |
Why?
|
| Family Health | 5 | 2020 | 1253 | 0.300 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 2068 | 0.300 |
Why?
|
| Cell Differentiation | 8 | 2024 | 11639 | 0.300 |
Why?
|
| Hydrops Fetalis | 2 | 2023 | 113 | 0.300 |
Why?
|
| Aneurysm | 1 | 2011 | 343 | 0.300 |
Why?
|
| Protein Transport | 5 | 2020 | 1938 | 0.290 |
Why?
|
| Muscle, Skeletal | 7 | 2021 | 4959 | 0.290 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2009 | 134 | 0.290 |
Why?
|
| Cysts | 1 | 2013 | 684 | 0.290 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2022 | 433 | 0.290 |
Why?
|
| Stroke | 2 | 2024 | 9739 | 0.290 |
Why?
|
| HEK293 Cells | 11 | 2022 | 4257 | 0.290 |
Why?
|
| Osteosclerosis | 2 | 2020 | 41 | 0.290 |
Why?
|
| Arabia | 2 | 2021 | 6 | 0.290 |
Why?
|
| Europe | 3 | 2021 | 3430 | 0.290 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2016 | 844 | 0.290 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2020 | 2157 | 0.290 |
Why?
|
| Cytoskeleton | 2 | 2016 | 1178 | 0.280 |
Why?
|
| Respiratory Mucosa | 2 | 2021 | 437 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2018 | 275 | 0.280 |
Why?
|
| Causality | 2 | 2023 | 1247 | 0.280 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 2018 | 99 | 0.280 |
Why?
|
| Cell Line | 13 | 2024 | 15540 | 0.270 |
Why?
|
| Fetal Diseases | 2 | 2023 | 915 | 0.270 |
Why?
|
| Exophthalmos | 2 | 2020 | 100 | 0.270 |
Why?
|
| Mitosis | 4 | 2021 | 1175 | 0.270 |
Why?
|
| SUMO-1 Protein | 1 | 2006 | 35 | 0.270 |
Why?
|
| Hypertelorism | 3 | 2021 | 29 | 0.270 |
Why?
|
| Endothelium, Corneal | 1 | 2009 | 212 | 0.270 |
Why?
|
| Electroencephalography | 3 | 2017 | 6274 | 0.270 |
Why?
|
| ADP-Ribosylation Factors | 3 | 2018 | 130 | 0.270 |
Why?
|
| Gene Expression | 8 | 2020 | 7581 | 0.260 |
Why?
|
| Thyroglobulin | 2 | 2017 | 111 | 0.260 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2006 | 68 | 0.260 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2270 | 0.260 |
Why?
|
| Germ-Line Mutation | 3 | 2024 | 1885 | 0.260 |
Why?
|
| Diabetic Retinopathy | 1 | 2015 | 1294 | 0.260 |
Why?
|
| Fertilization in Vitro | 3 | 2021 | 1301 | 0.260 |
Why?
|
| Research | 1 | 2014 | 1974 | 0.260 |
Why?
|
| Bone Diseases | 1 | 2009 | 411 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2020 | 3606 | 0.250 |
Why?
|
| Forkhead Transcription Factors | 3 | 2024 | 1623 | 0.250 |
Why?
|
| Cytokinesis | 2 | 2017 | 170 | 0.250 |
Why?
|
| Hypopituitarism | 2 | 2021 | 253 | 0.250 |
Why?
|
| Micrognathism | 2 | 2024 | 64 | 0.250 |
Why?
|
| Oxidoreductases | 2 | 2020 | 409 | 0.250 |
Why?
|
| Gene Knockdown Techniques | 8 | 2018 | 1601 | 0.250 |
Why?
|
| Mannosyltransferases | 3 | 2020 | 24 | 0.250 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2005 | 46 | 0.250 |
Why?
|
| Cell Adhesion Molecules | 3 | 2019 | 1609 | 0.250 |
Why?
|
| RNA Splice Sites | 3 | 2016 | 212 | 0.250 |
Why?
|
| Fluorescein Angiography | 3 | 2019 | 1047 | 0.240 |
Why?
|
| Sterol 14-Demethylase | 2 | 2016 | 4 | 0.240 |
Why?
|
| Amino Acid Motifs | 3 | 2019 | 924 | 0.240 |
Why?
|
| Liver Failure | 2 | 2022 | 252 | 0.240 |
Why?
|
| Symporters | 2 | 2020 | 362 | 0.240 |
Why?
|
| Patella | 2 | 2024 | 310 | 0.240 |
Why?
|
| Cells, Cultured | 12 | 2021 | 18962 | 0.240 |
Why?
|
| Ring Chromosomes | 1 | 2005 | 26 | 0.240 |
Why?
|
| Heredity | 2 | 2018 | 149 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 191 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2019 | 640 | 0.240 |
Why?
|
| RNA Splicing | 4 | 2019 | 902 | 0.240 |
Why?
|
| DNA Methylation | 4 | 2023 | 4424 | 0.230 |
Why?
|
| Meiosis | 2 | 2017 | 326 | 0.230 |
Why?
|
| Microsatellite Repeats | 3 | 2013 | 784 | 0.230 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2004 | 45 | 0.230 |
Why?
|
| Calcium | 1 | 2017 | 5769 | 0.230 |
Why?
|
| Viscera | 1 | 2005 | 138 | 0.230 |
Why?
|
| Bezoars | 1 | 2004 | 29 | 0.230 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2011 | 742 | 0.230 |
Why?
|
| Base Pairing | 1 | 2024 | 139 | 0.230 |
Why?
|
| Methanol | 1 | 2004 | 91 | 0.220 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2005 | 172 | 0.220 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2024 | 62 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 3637 | 0.220 |
Why?
|
| Vitrectomy | 2 | 2024 | 389 | 0.220 |
Why?
|
| Septo-Optic Dysplasia | 2 | 2020 | 8 | 0.220 |
Why?
|
| Tonometry, Ocular | 2 | 2016 | 238 | 0.220 |
Why?
|
| Retrospective Studies | 24 | 2024 | 81537 | 0.220 |
Why?
|
| Oncogene Proteins | 2 | 2018 | 710 | 0.220 |
Why?
|
| NFI Transcription Factors | 2 | 2018 | 49 | 0.220 |
Why?
|
| Qatar | 3 | 2019 | 40 | 0.220 |
Why?
|
| Ubiquitins | 2 | 2023 | 365 | 0.220 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 1884 | 0.220 |
Why?
|
| Hemoglobinopathies | 2 | 2019 | 101 | 0.220 |
Why?
|
| Prognosis | 11 | 2022 | 29890 | 0.220 |
Why?
|
| Signal Transduction | 10 | 2023 | 23597 | 0.220 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2020 | 615 | 0.220 |
Why?
|
| Neural Stem Cells | 2 | 2024 | 897 | 0.210 |
Why?
|
| Urethral Obstruction | 1 | 2023 | 56 | 0.210 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2020 | 1038 | 0.210 |
Why?
|
| Heart Diseases | 1 | 2016 | 2818 | 0.210 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 1961 | 0.210 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2023 | 48 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2013 | 370 | 0.210 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2023 | 57 | 0.210 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2019 | 2053 | 0.210 |
Why?
|
| Chromosomes, Human | 2 | 2017 | 437 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 451 | 0.210 |
Why?
|
| Workflow | 2 | 2018 | 859 | 0.210 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2022 | 37 | 0.210 |
Why?
|
| Pancreatic Diseases | 2 | 2016 | 353 | 0.210 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2024 | 2674 | 0.200 |
Why?
|
| Tibia | 1 | 2008 | 1064 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2024 | 69 | 0.200 |
Why?
|
| DNA, Mitochondrial | 2 | 2018 | 869 | 0.200 |
Why?
|
| Ferrets | 1 | 2023 | 181 | 0.200 |
Why?
|
| Loss of Heterozygosity | 2 | 2022 | 663 | 0.200 |
Why?
|
| Gene Components | 2 | 2012 | 27 | 0.200 |
Why?
|
| Thrombosis | 1 | 2016 | 2955 | 0.200 |
Why?
|
| Timolol | 2 | 2013 | 51 | 0.200 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4249 | 0.200 |
Why?
|
| Age of Onset | 6 | 2020 | 3343 | 0.200 |
Why?
|
| Zona Pellucida | 1 | 2021 | 15 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2023 | 1772 | 0.190 |
Why?
|
| Retinoscopy | 2 | 2012 | 27 | 0.190 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 91 | 0.190 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2021 | 10 | 0.190 |
Why?
|
| Turkey | 2 | 2020 | 281 | 0.190 |
Why?
|
| Lipoid Proteinosis of Urbach and Wiethe | 1 | 2021 | 4 | 0.190 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2021 | 5 | 0.190 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3000 | 0.190 |
Why?
|
| Phosphorylation | 4 | 2020 | 8279 | 0.190 |
Why?
|
| Ligases | 1 | 2023 | 330 | 0.190 |
Why?
|
| Collagen Type IX | 1 | 2021 | 20 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2021 | 683 | 0.190 |
Why?
|
| Retinal Perforations | 1 | 2023 | 136 | 0.190 |
Why?
|
| Oxygenases | 1 | 2021 | 59 | 0.190 |
Why?
|
| Holoprosencephaly | 1 | 2021 | 22 | 0.190 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 2 | 2022 | 21 | 0.190 |
Why?
|
| Mediator Complex | 2 | 2023 | 106 | 0.190 |
Why?
|
| Collagen | 2 | 2021 | 2616 | 0.190 |
Why?
|
| Pyrophosphatases | 1 | 2022 | 143 | 0.190 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2021 | 97 | 0.180 |
Why?
|
| Scavenger Receptors, Class F | 1 | 2021 | 16 | 0.180 |
Why?
|
| Genetic Complementation Test | 2 | 2014 | 556 | 0.180 |
Why?
|
| Crossing Over, Genetic | 1 | 2021 | 92 | 0.180 |
Why?
|
| Inbreeding | 1 | 2021 | 48 | 0.180 |
Why?
|
| Alternative Splicing | 2 | 2017 | 1103 | 0.180 |
Why?
|
| Hypertrichosis | 1 | 2021 | 31 | 0.180 |
Why?
|
| Narcolepsy | 1 | 2024 | 200 | 0.180 |
Why?
|
| Dermatitis, Exfoliative | 1 | 2021 | 28 | 0.180 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2021 | 41 | 0.180 |
Why?
|
| Eyeglasses | 2 | 2013 | 138 | 0.180 |
Why?
|
| Gene Conversion | 1 | 2021 | 69 | 0.180 |
Why?
|
| Genes | 2 | 2015 | 1824 | 0.180 |
Why?
|
| 4-1BB Ligand | 1 | 2020 | 28 | 0.180 |
Why?
|
| Skin Diseases | 1 | 2009 | 1083 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2017 | 4563 | 0.180 |
Why?
|
| Microvilli | 1 | 2021 | 234 | 0.180 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2020 | 18 | 0.180 |
Why?
|
| Liver Failure, Acute | 1 | 2022 | 183 | 0.180 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 2020 | 8 | 0.180 |
Why?
|
| RNA, Transfer, Arg | 1 | 2020 | 2 | 0.180 |
Why?
|
| Amidohydrolases | 1 | 2021 | 161 | 0.180 |
Why?
|
| Hypopigmentation | 1 | 2021 | 43 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 386 | 0.180 |
Why?
|
| Oocyte Retrieval | 1 | 2022 | 162 | 0.180 |
Why?
|
| Collagen Type II | 1 | 2021 | 151 | 0.180 |
Why?
|
| Aconitate Hydratase | 1 | 2020 | 17 | 0.180 |
Why?
|
| Mucolipidoses | 1 | 2021 | 82 | 0.180 |
Why?
|
| Nail Diseases | 1 | 2021 | 54 | 0.180 |
Why?
|
| History, Ancient | 1 | 2021 | 213 | 0.180 |
Why?
|
| Malabsorption Syndromes | 1 | 2021 | 135 | 0.170 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2020 | 28 | 0.170 |
Why?
|
| Islam | 1 | 2001 | 72 | 0.170 |
Why?
|
| Type C Phospholipases | 1 | 2021 | 284 | 0.170 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2020 | 8 | 0.170 |
Why?
|
| Trichothiodystrophy Syndromes | 1 | 2019 | 2 | 0.170 |
Why?
|
| BRCA2 Protein | 2 | 2016 | 802 | 0.170 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2020 | 116 | 0.170 |
Why?
|
| Neurogenesis | 2 | 2024 | 863 | 0.170 |
Why?
|
| Microtubule Proteins | 1 | 2020 | 61 | 0.170 |
Why?
|
| Sleep | 1 | 2016 | 4818 | 0.170 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2020 | 66 | 0.170 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2020 | 29 | 0.170 |
Why?
|
| Preconception Care | 1 | 2021 | 143 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 812 | 0.170 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2020 | 141 | 0.170 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2021 | 452 | 0.170 |
Why?
|
| Calpain | 1 | 2020 | 146 | 0.170 |
Why?
|
| Thyroid Neoplasms | 3 | 2019 | 2354 | 0.170 |
Why?
|
| Gene Silencing | 3 | 2016 | 1504 | 0.170 |
Why?
|
| Soybean Oil | 1 | 2021 | 139 | 0.170 |
Why?
|
| Nose Diseases | 1 | 2020 | 78 | 0.170 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2012 | 3796 | 0.170 |
Why?
|
| Caenorhabditis elegans | 4 | 2023 | 1480 | 0.170 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2019 | 24 | 0.170 |
Why?
|
| Nodal Protein | 1 | 2019 | 36 | 0.170 |
Why?
|
| Clubfoot | 1 | 2020 | 87 | 0.170 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 89 | 0.170 |
Why?
|
| Fundus Oculi | 2 | 2019 | 542 | 0.170 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2012 | 298 | 0.170 |
Why?
|
| Sequence Homology | 1 | 2020 | 197 | 0.170 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2023 | 176 | 0.170 |
Why?
|
| DNA Transposable Elements | 1 | 2023 | 765 | 0.170 |
Why?
|
| Biometry | 2 | 2013 | 571 | 0.170 |
Why?
|
| Nails, Malformed | 1 | 2019 | 34 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2024 | 526 | 0.160 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2021 | 164 | 0.160 |
Why?
|
| Pharmacogenetics | 1 | 2023 | 682 | 0.160 |
Why?
|
| Co-Repressor Proteins | 2 | 2021 | 189 | 0.160 |
Why?
|
| Glutamate Decarboxylase | 1 | 2020 | 239 | 0.160 |
Why?
|
| Cholangitis | 1 | 2020 | 110 | 0.160 |
Why?
|
| Speech Disorders | 1 | 2020 | 178 | 0.160 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2019 | 73 | 0.160 |
Why?
|
| Receptors, Interleukin | 1 | 2020 | 243 | 0.160 |
Why?
|
| Dependovirus | 2 | 2016 | 721 | 0.160 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2019 | 83 | 0.160 |
Why?
|
| Middle Aged | 28 | 2024 | 223016 | 0.160 |
Why?
|
| Chromosomes, Human, Y | 1 | 2020 | 163 | 0.160 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 83 | 0.160 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 1775 | 0.160 |
Why?
|
| Receptors, Cytokine | 2 | 2020 | 257 | 0.160 |
Why?
|
| Asia | 1 | 2021 | 630 | 0.160 |
Why?
|
| Penetrance | 2 | 2018 | 388 | 0.160 |
Why?
|
| Spermatogenesis | 2 | 2018 | 259 | 0.160 |
Why?
|
| Cytosine | 1 | 2020 | 212 | 0.160 |
Why?
|
| Ataxia | 1 | 2021 | 307 | 0.160 |
Why?
|
| Jaundice, Obstructive | 1 | 2018 | 22 | 0.160 |
Why?
|
| Seminiferous Tubules | 1 | 2018 | 25 | 0.150 |
Why?
|
| Sotos Syndrome | 1 | 2018 | 10 | 0.150 |
Why?
|
| Spermatids | 1 | 2018 | 36 | 0.150 |
Why?
|
| Glycosylation | 3 | 2022 | 1099 | 0.150 |
Why?
|
| Endothelin-1 | 1 | 2020 | 295 | 0.150 |
Why?
|
| Autoimmunity | 2 | 2024 | 1354 | 0.150 |
Why?
|
| Africa | 1 | 2021 | 725 | 0.150 |
Why?
|
| Receptors, Lipoprotein | 1 | 2018 | 88 | 0.150 |
Why?
|
| F-Box Proteins | 2 | 2017 | 199 | 0.150 |
Why?
|
| Germ Cells | 1 | 2022 | 646 | 0.150 |
Why?
|
| alpha-Macroglobulins | 1 | 2018 | 60 | 0.150 |
Why?
|
| Cataract Extraction | 2 | 2014 | 463 | 0.150 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2014 | 597 | 0.150 |
Why?
|
| Evolution, Molecular | 3 | 2019 | 1889 | 0.150 |
Why?
|
| Rifampin | 1 | 2020 | 350 | 0.150 |
Why?
|
| Corpus Callosum | 1 | 2023 | 751 | 0.150 |
Why?
|
| Libya | 1 | 2017 | 9 | 0.150 |
Why?
|
| Abortion, Induced | 2 | 2019 | 471 | 0.150 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2018 | 85 | 0.150 |
Why?
|
| Collagen Type I | 2 | 2012 | 616 | 0.150 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2020 | 219 | 0.150 |
Why?
|
| DNA Replication | 3 | 2024 | 1428 | 0.150 |
Why?
|
| In Situ Hybridization | 3 | 2013 | 1885 | 0.150 |
Why?
|
| Exoribonucleases | 1 | 2018 | 88 | 0.150 |
Why?
|
| United Arab Emirates | 1 | 2017 | 42 | 0.150 |
Why?
|
| Embryo Transfer | 1 | 2022 | 526 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 14643 | 0.150 |
Why?
|
| Neurons | 6 | 2024 | 9527 | 0.150 |
Why?
|
| Prospective Studies | 10 | 2023 | 54807 | 0.140 |
Why?
|
| Chromosomal Position Effects | 1 | 2017 | 12 | 0.140 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 947 | 0.140 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2018 | 175 | 0.140 |
Why?
|
| Diagnosis | 1 | 2018 | 157 | 0.140 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2013 | 291 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3140 | 0.140 |
Why?
|
| Receptor, TIE-2 | 1 | 2018 | 183 | 0.140 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2017 | 30 | 0.140 |
Why?
|
| Cor Triatriatum | 1 | 2017 | 14 | 0.140 |
Why?
|
| Glycoproteins | 2 | 2018 | 2196 | 0.140 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2016 | 8 | 0.140 |
Why?
|
| Cell Movement | 8 | 2021 | 5190 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2020 | 844 | 0.140 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22228 | 0.140 |
Why?
|
| Chromosomes, Human, X | 2 | 2011 | 319 | 0.140 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2017 | 44 | 0.140 |
Why?
|
| Phospholipids | 1 | 2021 | 776 | 0.140 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2011 | 407 | 0.140 |
Why?
|
| Tomography, Optical Coherence | 4 | 2016 | 2876 | 0.140 |
Why?
|
| Demyelinating Diseases | 1 | 2019 | 355 | 0.140 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 325 | 0.140 |
Why?
|
| Hyperglycinemia, Nonketotic | 1 | 2016 | 2 | 0.140 |
Why?
|
| Cell Division | 1 | 2024 | 4466 | 0.140 |
Why?
|
| Information Dissemination | 2 | 2023 | 1142 | 0.140 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 780 | 0.140 |
Why?
|
| Acyl Coenzyme A | 1 | 2016 | 56 | 0.140 |
Why?
|
| Glutathione Synthase | 1 | 2016 | 3 | 0.140 |
Why?
|
| Epidermis | 1 | 2020 | 535 | 0.140 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2018 | 474 | 0.140 |
Why?
|
| Hydranencephaly | 1 | 2016 | 5 | 0.140 |
Why?
|
| Herpesvirus 4, Human | 2 | 2020 | 1077 | 0.140 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 12973 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2020 | 1281 | 0.140 |
Why?
|
| Vascular Malformations | 1 | 2022 | 470 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 327 | 0.140 |
Why?
|
| Phagocytes | 1 | 2018 | 292 | 0.140 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2017 | 138 | 0.130 |
Why?
|
| Nerve Growth Factors | 1 | 2019 | 564 | 0.130 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2018 | 216 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 292 | 0.130 |
Why?
|
| Fatty Acids | 2 | 2016 | 1804 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2010 | 3965 | 0.130 |
Why?
|
| Hypothyroidism | 2 | 2014 | 665 | 0.130 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2016 | 47 | 0.130 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2016 | 66 | 0.130 |
Why?
|
| Genetic Vectors | 3 | 2016 | 3400 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 20133 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2021 | 1130 | 0.130 |
Why?
|
| Attitude | 1 | 2001 | 768 | 0.130 |
Why?
|
| Corneal Topography | 2 | 2015 | 69 | 0.130 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2015 | 21 | 0.130 |
Why?
|
| Trismus | 1 | 2016 | 33 | 0.130 |
Why?
|
| Metabolome | 2 | 2022 | 1005 | 0.130 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2017 | 108 | 0.130 |
Why?
|
| Subretinal Fluid | 1 | 2016 | 24 | 0.130 |
Why?
|
| Telomere | 2 | 2016 | 941 | 0.130 |
Why?
|
| Computer Simulation | 3 | 2021 | 6251 | 0.130 |
Why?
|
| Software | 3 | 2016 | 4462 | 0.130 |
Why?
|
| Hyperhidrosis | 1 | 2016 | 34 | 0.130 |
Why?
|
| DNA Adducts | 1 | 2016 | 94 | 0.130 |
Why?
|
| Hand | 2 | 2012 | 908 | 0.130 |
Why?
|
| Connective Tissue | 1 | 2018 | 425 | 0.130 |
Why?
|
| Leigh Disease | 1 | 2016 | 88 | 0.130 |
Why?
|
| Livedo Reticularis | 1 | 2015 | 5 | 0.130 |
Why?
|
| Malignant Hyperthermia | 1 | 2015 | 72 | 0.130 |
Why?
|
| Xenopus Proteins | 1 | 2018 | 433 | 0.130 |
Why?
|
| Aicardi Syndrome | 1 | 2015 | 16 | 0.120 |
Why?
|
| Luciferases | 1 | 2017 | 712 | 0.120 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 388 | 0.120 |
Why?
|
| Autophagy | 2 | 2021 | 1350 | 0.120 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 480 | 0.120 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 1787 | 0.120 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2015 | 167 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 1060 | 0.120 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 361 | 0.120 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 3048 | 0.120 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2016 | 244 | 0.120 |
Why?
|
| RNA Interference | 2 | 2015 | 2829 | 0.120 |
Why?
|
| RNA Stability | 1 | 2017 | 319 | 0.120 |
Why?
|
| Acetylation | 3 | 2024 | 1054 | 0.120 |
Why?
|
| Enkephalins | 1 | 2015 | 139 | 0.120 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2016 | 173 | 0.120 |
Why?
|
| Collagen Diseases | 1 | 2015 | 38 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 280 | 0.120 |
Why?
|
| Gene Dosage | 2 | 2012 | 1213 | 0.120 |
Why?
|
| De Lange Syndrome | 1 | 2015 | 22 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 547 | 0.120 |
Why?
|
| Periosteum | 1 | 2015 | 138 | 0.120 |
Why?
|
| Immune System Diseases | 1 | 2017 | 253 | 0.120 |
Why?
|
| RGS Proteins | 1 | 2014 | 75 | 0.120 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 273 | 0.120 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2014 | 42 | 0.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2015 | 185 | 0.120 |
Why?
|
| Phylogeny | 2 | 2013 | 2837 | 0.120 |
Why?
|
| Models, Genetic | 3 | 2020 | 3447 | 0.120 |
Why?
|
| Nephrotic Syndrome | 1 | 2018 | 380 | 0.120 |
Why?
|
| Lung | 2 | 2024 | 10046 | 0.120 |
Why?
|
| Macaca | 1 | 2016 | 413 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2017 | 2510 | 0.110 |
Why?
|
| Photoreceptor Cells | 1 | 2015 | 234 | 0.110 |
Why?
|
| TRPM Cation Channels | 1 | 2015 | 139 | 0.110 |
Why?
|
| Kartagener Syndrome | 1 | 2014 | 33 | 0.110 |
Why?
|
| Protein Stability | 2 | 2018 | 576 | 0.110 |
Why?
|
| Internationality | 1 | 2019 | 1007 | 0.110 |
Why?
|
| Lysosomes | 1 | 2019 | 932 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2014 | 1498 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2020 | 3583 | 0.110 |
Why?
|
| Comet Assay | 1 | 2013 | 74 | 0.110 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 943 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 2 | 2015 | 839 | 0.110 |
Why?
|
| Hearing Loss | 1 | 2021 | 785 | 0.110 |
Why?
|
| Eyelid Diseases | 1 | 2015 | 155 | 0.110 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 36 | 0.110 |
Why?
|
| Risk Factors | 5 | 2024 | 74850 | 0.110 |
Why?
|
| Growth Hormone | 1 | 2016 | 567 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 2411 | 0.110 |
Why?
|
| Cytosol | 1 | 2016 | 885 | 0.110 |
Why?
|
| Exosomes | 1 | 2018 | 417 | 0.110 |
Why?
|
| Craniosynostoses | 2 | 2015 | 415 | 0.110 |
Why?
|
| Deaf-Blind Disorders | 1 | 2013 | 4 | 0.110 |
Why?
|
| Connexins | 1 | 2015 | 355 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 710 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2017 | 1524 | 0.110 |
Why?
|
| DNA Glycosylases | 1 | 2014 | 125 | 0.110 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 207 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 3690 | 0.110 |
Why?
|
| Leukopenia | 1 | 2013 | 213 | 0.110 |
Why?
|
| Myofibrils | 1 | 2013 | 143 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2020 | 5752 | 0.100 |
Why?
|
| Nephritis, Hereditary | 1 | 2013 | 78 | 0.100 |
Why?
|
| Antigens, Neoplasm | 2 | 2012 | 1995 | 0.100 |
Why?
|
| Endpoint Determination | 1 | 2016 | 591 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 9525 | 0.100 |
Why?
|
| Introns | 1 | 2015 | 965 | 0.100 |
Why?
|
| Keratoconus | 1 | 2015 | 112 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2016 | 618 | 0.100 |
Why?
|
| Apraxias | 1 | 2013 | 58 | 0.100 |
Why?
|
| Motor Neurons | 1 | 2018 | 871 | 0.100 |
Why?
|
| Drosophila melanogaster | 4 | 2023 | 1725 | 0.100 |
Why?
|
| Axial Length, Eye | 1 | 2012 | 36 | 0.100 |
Why?
|
| Insulin Resistance | 2 | 2022 | 3988 | 0.100 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 1 | 2012 | 17 | 0.100 |
Why?
|
| Helicobacter pylori | 1 | 2016 | 380 | 0.100 |
Why?
|
| Kuwait | 1 | 2012 | 94 | 0.100 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2012 | 15 | 0.100 |
Why?
|
| Fetus | 1 | 2020 | 1878 | 0.100 |
Why?
|
| Methylation | 1 | 2015 | 1074 | 0.100 |
Why?
|
| Hyperopia | 1 | 2012 | 41 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2013 | 124 | 0.100 |
Why?
|
| Helicobacter Infections | 1 | 2016 | 390 | 0.100 |
Why?
|
| Mammals | 3 | 2023 | 1126 | 0.100 |
Why?
|
| INDEL Mutation | 1 | 2013 | 267 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2018 | 1186 | 0.100 |
Why?
|
| Receptor, EphA2 | 1 | 2012 | 41 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2017 | 716 | 0.100 |
Why?
|
| Liver | 1 | 2008 | 7559 | 0.100 |
Why?
|
| Reflex, Abnormal | 1 | 2012 | 83 | 0.100 |
Why?
|
| Pituitary Hormones | 1 | 2013 | 183 | 0.100 |
Why?
|
| Globus Pallidus | 1 | 2013 | 247 | 0.100 |
Why?
|
| Ophthalmoscopy | 1 | 2013 | 170 | 0.100 |
Why?
|
| Collagen Type VIII | 1 | 2012 | 15 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 361 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 412 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2013 | 2028 | 0.100 |
Why?
|
| Connexin 43 | 1 | 2013 | 201 | 0.100 |
Why?
|
| Monoamine Oxidase | 1 | 2012 | 179 | 0.100 |
Why?
|
| Diabetes Mellitus | 4 | 2019 | 5889 | 0.100 |
Why?
|
| Ubiquitination | 2 | 2013 | 996 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 566 | 0.100 |
Why?
|
| Sclera | 1 | 2013 | 189 | 0.100 |
Why?
|
| Morbidity | 1 | 2017 | 1752 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 975 | 0.100 |
Why?
|
| Bone Marrow Diseases | 1 | 2013 | 234 | 0.100 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2011 | 22 | 0.090 |
Why?
|
| Anemia, Aplastic | 1 | 2013 | 231 | 0.090 |
Why?
|
| Spinal Cord | 2 | 2018 | 1786 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2024 | 723 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1167 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 446 | 0.090 |
Why?
|
| Histidine | 2 | 2022 | 301 | 0.090 |
Why?
|
| Collectins | 1 | 2011 | 16 | 0.090 |
Why?
|
| Mydriasis | 1 | 2011 | 13 | 0.090 |
Why?
|
| Refractive Errors | 1 | 2013 | 148 | 0.090 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2011 | 20 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 2014 | 697 | 0.090 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2011 | 28 | 0.090 |
Why?
|
| Craniofacial Dysostosis | 1 | 2011 | 74 | 0.090 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 2010 | 5 | 0.090 |
Why?
|
| Glutarates | 1 | 2013 | 243 | 0.090 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 2010 | 13 | 0.090 |
Why?
|
| Protein Precursors | 1 | 2015 | 1133 | 0.090 |
Why?
|
| Stillbirth | 1 | 2014 | 381 | 0.090 |
Why?
|
| Lymphoma | 1 | 2020 | 1896 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3419 | 0.090 |
Why?
|
| Rats | 5 | 2022 | 23708 | 0.090 |
Why?
|
| Ectropion | 1 | 2011 | 27 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 533 | 0.090 |
Why?
|
| Collagen Type VI | 1 | 2010 | 26 | 0.090 |
Why?
|
| Gonioscopy | 1 | 2011 | 157 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 786 | 0.090 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2011 | 142 | 0.090 |
Why?
|
| Deafness | 2 | 2020 | 461 | 0.090 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 1178 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2012 | 539 | 0.090 |
Why?
|
| Nystagmus, Pathologic | 1 | 2011 | 104 | 0.090 |
Why?
|
| International Cooperation | 1 | 2017 | 1433 | 0.090 |
Why?
|
| Head Movements | 1 | 2011 | 149 | 0.090 |
Why?
|
| Brain Stem | 1 | 2015 | 854 | 0.090 |
Why?
|
| Lipoproteins | 1 | 2015 | 870 | 0.090 |
Why?
|
| Syntaxin 16 | 1 | 2010 | 9 | 0.090 |
Why?
|
| Pelvic Bones | 1 | 2012 | 273 | 0.090 |
Why?
|
| Scotoma | 1 | 2011 | 127 | 0.090 |
Why?
|
| Ligase Chain Reaction | 1 | 2010 | 8 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1961 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 204 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 542 | 0.090 |
Why?
|
| CDC2 Protein Kinase | 1 | 2011 | 212 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 12235 | 0.090 |
Why?
|
| Ear, Inner | 2 | 2018 | 426 | 0.090 |
Why?
|
| Physical Examination | 1 | 2016 | 1263 | 0.090 |
Why?
|
| Aqueous Humor | 1 | 2010 | 150 | 0.090 |
Why?
|
| Microscopy, Video | 2 | 2021 | 241 | 0.090 |
Why?
|
| Inosine | 2 | 2022 | 129 | 0.090 |
Why?
|
| Vitamin D | 1 | 2024 | 3272 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
| BRCA1 Protein | 1 | 2016 | 1155 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 2 | 2023 | 523 | 0.080 |
Why?
|
| Endopeptidases | 1 | 2013 | 760 | 0.080 |
Why?
|
| Osteoblasts | 1 | 2015 | 1143 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 1748 | 0.080 |
Why?
|
| Aphakia, Postcataract | 1 | 2010 | 51 | 0.080 |
Why?
|
| Retinoschisis | 1 | 2010 | 29 | 0.080 |
Why?
|
| Adrenal Insufficiency | 1 | 2012 | 194 | 0.080 |
Why?
|
| beta Catenin | 1 | 2015 | 1046 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2010 | 127 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1308 | 0.080 |
Why?
|
| COUP Transcription Factor I | 1 | 2009 | 12 | 0.080 |
Why?
|
| Amblyopia | 1 | 2012 | 152 | 0.080 |
Why?
|
| Cerebral Cortex | 3 | 2020 | 5765 | 0.080 |
Why?
|
| Cell Proliferation | 5 | 2020 | 10426 | 0.080 |
Why?
|
| DNA Repair | 2 | 2016 | 2048 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 7 | 2022 | 22327 | 0.080 |
Why?
|
| Molecular Probe Techniques | 1 | 2010 | 111 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 1563 | 0.080 |
Why?
|
| Aging, Premature | 1 | 2009 | 44 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 495 | 0.080 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2009 | 53 | 0.080 |
Why?
|
| Chromogranins | 1 | 2010 | 159 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2120 | 0.080 |
Why?
|
| Hepatitis B, Chronic | 1 | 2013 | 413 | 0.080 |
Why?
|
| Homeostasis | 2 | 2017 | 3338 | 0.080 |
Why?
|
| Netherlands | 3 | 2020 | 2277 | 0.080 |
Why?
|
| Protein Binding | 5 | 2020 | 9296 | 0.080 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 2008 | 17 | 0.080 |
Why?
|
| DNA Helicases | 2 | 2018 | 852 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2018 | 1949 | 0.080 |
Why?
|
| Uterus | 1 | 2012 | 660 | 0.080 |
Why?
|
| Esotropia | 1 | 2010 | 99 | 0.080 |
Why?
|
| Binding Sites | 1 | 2017 | 5999 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2661 | 0.080 |
Why?
|
| Threonine | 1 | 2009 | 272 | 0.080 |
Why?
|
| Obesity | 2 | 2022 | 13082 | 0.080 |
Why?
|
| Chromosome Inversion | 1 | 2009 | 119 | 0.080 |
Why?
|
| Scoliosis | 1 | 2015 | 793 | 0.080 |
Why?
|
| Physical Chromosome Mapping | 1 | 2008 | 183 | 0.080 |
Why?
|
| Choanal Atresia | 1 | 2008 | 41 | 0.080 |
Why?
|
| Thiophenes | 1 | 2013 | 570 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 632 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 852 | 0.080 |
Why?
|
| Drosophila | 3 | 2024 | 1505 | 0.080 |
Why?
|
| Protein Isoforms | 3 | 2020 | 1716 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2018 | 2596 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 195 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2022 | 303 | 0.070 |
Why?
|
| Hearing Disorders | 1 | 2008 | 126 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 326 | 0.070 |
Why?
|
| Foot | 1 | 2012 | 575 | 0.070 |
Why?
|
| Disease Management | 1 | 2018 | 2530 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 2470 | 0.070 |
Why?
|
| Mouth | 1 | 2010 | 382 | 0.070 |
Why?
|
| Abortion, Spontaneous | 1 | 2013 | 536 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 760 | 0.070 |
Why?
|
| Ear, External | 1 | 2008 | 164 | 0.070 |
Why?
|
| Proline | 1 | 2009 | 452 | 0.070 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 1996 | 0.070 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2008 | 82 | 0.070 |
Why?
|
| Recurrence | 1 | 2020 | 8492 | 0.070 |
Why?
|
| Chloride Channels | 2 | 2022 | 221 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1138 | 0.070 |
Why?
|
| Transfection | 2 | 2015 | 5738 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2012 | 1865 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2019 | 3070 | 0.070 |
Why?
|
| Carrier State | 1 | 2011 | 529 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3749 | 0.070 |
Why?
|
| Neural Crest | 2 | 2011 | 277 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 128 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3447 | 0.070 |
Why?
|
| Skin | 3 | 2021 | 4481 | 0.070 |
Why?
|
| Fetal Development | 1 | 2012 | 777 | 0.070 |
Why?
|
| Retinal Diseases | 1 | 2013 | 702 | 0.070 |
Why?
|
| Human Development | 1 | 2008 | 122 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2013 | 1307 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2017 | 4130 | 0.070 |
Why?
|
| Translocation, Genetic | 2 | 2017 | 1393 | 0.070 |
Why?
|
| Cause of Death | 1 | 2017 | 3715 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 6491 | 0.070 |
Why?
|
| Chick Embryo | 2 | 2023 | 964 | 0.070 |
Why?
|
| Calcinosis | 1 | 2015 | 1475 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 1363 | 0.070 |
Why?
|
| Body Height | 1 | 2012 | 1561 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 39228 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2009 | 793 | 0.070 |
Why?
|
| Monosomy | 1 | 2006 | 52 | 0.060 |
Why?
|
| Nasal Mucosa | 1 | 2009 | 416 | 0.060 |
Why?
|
| Palate | 1 | 2006 | 126 | 0.060 |
Why?
|
| Oxidation-Reduction | 3 | 2018 | 2219 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2014 | 2492 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 1172 | 0.060 |
Why?
|
| Proteome | 3 | 2021 | 1896 | 0.060 |
Why?
|
| Tunisia | 2 | 2014 | 40 | 0.060 |
Why?
|
| Ethanolamine | 1 | 2024 | 9 | 0.060 |
Why?
|
| Visual Perception | 1 | 2013 | 1393 | 0.060 |
Why?
|
| B-Lymphocytes | 2 | 2019 | 4782 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 17060 | 0.060 |
Why?
|
| RNA Polymerase III | 1 | 2024 | 59 | 0.060 |
Why?
|
| Visual Fields | 1 | 2011 | 1062 | 0.060 |
Why?
|
| Disease Progression | 2 | 2019 | 13614 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2213 | 0.060 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2024 | 7 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2011 | 1318 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 2206 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 2248 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 457 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1893 | 0.060 |
Why?
|
| Birth Weight | 1 | 2012 | 2122 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1489 | 0.060 |
Why?
|
| Health Policy | 1 | 2017 | 2699 | 0.060 |
Why?
|
| Neuroglia | 2 | 2020 | 963 | 0.060 |
Why?
|
| Nanopores | 1 | 2024 | 45 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 11030 | 0.060 |
Why?
|
| Anemia | 1 | 2013 | 1514 | 0.060 |
Why?
|
| Italy | 2 | 2019 | 851 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6544 | 0.060 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 103 | 0.050 |
Why?
|
| CADASIL | 1 | 2024 | 83 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2014 | 2916 | 0.050 |
Why?
|
| Public Health | 1 | 2017 | 2680 | 0.050 |
Why?
|
| Scleral Buckling | 1 | 2024 | 94 | 0.050 |
Why?
|
| Cataplexy | 1 | 2024 | 62 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 2 | 2017 | 502 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 15828 | 0.050 |
Why?
|
| Mannosidases | 1 | 2022 | 21 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 810 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2013 | 1979 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2022 | 15 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4904 | 0.050 |
Why?
|
| Poisoning | 1 | 2004 | 254 | 0.050 |
Why?
|
| NADP | 1 | 2024 | 228 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 33 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6306 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2021 | 1727 | 0.050 |
Why?
|
| Fibrosis | 1 | 2010 | 2073 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2006 | 743 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 511 | 0.050 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 32 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2004 | 434 | 0.050 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2022 | 71 | 0.050 |
Why?
|
| Inosine Triphosphate | 1 | 2022 | 1 | 0.050 |
Why?
|
| Muscle Cramp | 1 | 2022 | 33 | 0.050 |
Why?
|
| Xenopus laevis | 2 | 2018 | 965 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2022 | 150 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12059 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 398 | 0.050 |
Why?
|
| Genes, X-Linked | 1 | 2022 | 129 | 0.050 |
Why?
|
| Echocardiography | 1 | 2015 | 5040 | 0.050 |
Why?
|
| I-kappa B Kinase | 1 | 2023 | 249 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 127 | 0.050 |
Why?
|
| Ubiquitin | 2 | 2017 | 839 | 0.050 |
Why?
|
| Sensory Rhodopsins | 1 | 2021 | 1 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2024 | 791 | 0.050 |
Why?
|
| Milk | 1 | 2004 | 436 | 0.050 |
Why?
|
| Cheilitis | 1 | 2021 | 7 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2022 | 262 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2023 | 2920 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 636 | 0.050 |
Why?
|
| Tubulin | 2 | 2017 | 693 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2022 | 419 | 0.050 |
Why?
|
| Primates | 1 | 2023 | 518 | 0.050 |
Why?
|
| Pentosyltransferases | 1 | 2020 | 62 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 1204 | 0.050 |
Why?
|
| Vomiting | 1 | 2004 | 646 | 0.050 |
Why?
|
| Chromatin | 2 | 2023 | 2979 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 280 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10256 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2024 | 650 | 0.050 |
Why?
|
| Cystic Fibrosis | 2 | 2021 | 1284 | 0.040 |
Why?
|
| Nitrogen | 1 | 2022 | 344 | 0.040 |
Why?
|
| Keratosis | 1 | 2021 | 81 | 0.040 |
Why?
|
| Egypt | 1 | 2020 | 100 | 0.040 |
Why?
|
| Blister | 1 | 2021 | 88 | 0.040 |
Why?
|
| Emulsions | 1 | 2021 | 150 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2020 | 6870 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2023 | 2864 | 0.040 |
Why?
|
| Proteinuria | 1 | 2023 | 606 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2020 | 163 | 0.040 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 109 | 0.040 |
Why?
|
| Phosphates | 1 | 2024 | 763 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2021 | 139 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2021 | 230 | 0.040 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2020 | 110 | 0.040 |
Why?
|
| Oncostatin M | 1 | 2020 | 42 | 0.040 |
Why?
|
| Interleukin-11 | 1 | 2020 | 58 | 0.040 |
Why?
|
| Tay-Sachs Disease | 1 | 2019 | 20 | 0.040 |
Why?
|
| Ranvier's Nodes | 1 | 2019 | 19 | 0.040 |
Why?
|
| Stomach | 1 | 2004 | 702 | 0.040 |
Why?
|
| Secretory Pathway | 1 | 2020 | 53 | 0.040 |
Why?
|
| Cyprus | 1 | 2019 | 96 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2020 | 81 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 377 | 0.040 |
Why?
|
| Respiratory System Abnormalities | 1 | 2020 | 67 | 0.040 |
Why?
|
| Malaysia | 1 | 2019 | 107 | 0.040 |
Why?
|
| Pakistan | 1 | 2020 | 300 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2023 | 663 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 915 | 0.040 |
Why?
|
| Procollagen | 1 | 2020 | 189 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3816 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2019 | 218 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 8725 | 0.040 |
Why?
|
| Capillaries | 1 | 2022 | 751 | 0.040 |
Why?
|
| Glutamine | 1 | 2022 | 574 | 0.040 |
Why?
|
| Thalassemia | 1 | 2019 | 267 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2020 | 343 | 0.040 |
Why?
|
| Esophagus | 1 | 2005 | 1038 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 1314 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 242 | 0.040 |
Why?
|
| Respiratory Burst | 1 | 2018 | 107 | 0.040 |
Why?
|
| Cognition | 1 | 2016 | 7043 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 2021 | 633 | 0.040 |
Why?
|
| Microtubules | 2 | 2015 | 1062 | 0.040 |
Why?
|
| Caspase 7 | 1 | 2017 | 51 | 0.040 |
Why?
|
| RNA | 2 | 2022 | 2716 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2004 | 1069 | 0.040 |
Why?
|
| Preimplantation Diagnosis | 1 | 2019 | 143 | 0.040 |
Why?
|
| Musculoskeletal System | 1 | 2020 | 187 | 0.040 |
Why?
|
| X Chromosome Inactivation | 1 | 2019 | 229 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2020 | 711 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7423 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 65194 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2017 | 93 | 0.040 |
Why?
|
| Aged | 7 | 2024 | 171163 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2024 | 2001 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 454 | 0.040 |
Why?
|
| Pruritus | 1 | 2021 | 376 | 0.040 |
Why?
|
| Israel | 1 | 2019 | 729 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2023 | 1139 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2023 | 1155 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6958 | 0.030 |
Why?
|
| Sperm Motility | 1 | 2018 | 265 | 0.030 |
Why?
|
| Transferases | 1 | 2016 | 71 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2020 | 900 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2016 | 323 | 0.030 |
Why?
|
| Respiratory System | 1 | 2020 | 562 | 0.030 |
Why?
|
| Dyspnea | 1 | 2004 | 1351 | 0.030 |
Why?
|
| Constipation | 1 | 2021 | 568 | 0.030 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2016 | 95 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 2227 | 0.030 |
Why?
|
| Australia | 1 | 2019 | 1260 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1017 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 329 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2016 | 187 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2017 | 187 | 0.030 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 2015 | 68 | 0.030 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2017 | 437 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 2019 | 491 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2019 | 652 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2023 | 1343 | 0.030 |
Why?
|
| Genome | 1 | 2023 | 1753 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 386 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2017 | 228 | 0.030 |
Why?
|
| Urticaria | 1 | 2016 | 151 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 472 | 0.030 |
Why?
|
| Exonucleases | 1 | 2015 | 42 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 5364 | 0.030 |
Why?
|
| Remission Induction | 1 | 2021 | 2413 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2020 | 798 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 142 | 0.030 |
Why?
|
| Refraction, Ocular | 1 | 2015 | 188 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2023 | 1704 | 0.030 |
Why?
|
| Cell Separation | 1 | 2020 | 1718 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 2015 | 222 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3049 | 0.030 |
Why?
|
| Sacrum | 1 | 2015 | 270 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 54 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 5019 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 588 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2019 | 952 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 740 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2001 | 2740 | 0.030 |
Why?
|
| Stem Cells | 1 | 2006 | 3537 | 0.030 |
Why?
|
| Leviviridae | 1 | 2013 | 1 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1132 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15802 | 0.030 |
Why?
|
| Sarcomeres | 1 | 2016 | 379 | 0.030 |
Why?
|
| Policy Making | 1 | 2017 | 546 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 2016 | 663 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2014 | 463 | 0.030 |
Why?
|
| Glycine | 1 | 2016 | 671 | 0.030 |
Why?
|
| Genitalia, Male | 1 | 2013 | 87 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2022 | 1833 | 0.030 |
Why?
|
| Anticodon | 1 | 2012 | 24 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2013 | 528 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 2012 | 59 | 0.030 |
Why?
|
| Vasculitis | 1 | 2016 | 528 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2013 | 273 | 0.020 |
Why?
|
| Kinetics | 1 | 2020 | 6273 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2020 | 1866 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2014 | 225 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 486 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 871 | 0.020 |
Why?
|
| Axons | 1 | 2019 | 1678 | 0.020 |
Why?
|
| Heart Failure | 1 | 2016 | 11837 | 0.020 |
Why?
|
| Crystallins | 1 | 2011 | 75 | 0.020 |
Why?
|
| ras Proteins | 1 | 2016 | 1054 | 0.020 |
Why?
|
| Melanosomes | 1 | 2011 | 34 | 0.020 |
Why?
|
| Cytokines | 2 | 2016 | 7417 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 2331 | 0.020 |
Why?
|
| Urinalysis | 1 | 2013 | 369 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2011 | 316 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2141 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 2729 | 0.020 |
Why?
|
| Program Development | 1 | 2017 | 1297 | 0.020 |
Why?
|
| Models, Biological | 2 | 2020 | 9443 | 0.020 |
Why?
|
| Rabbits | 1 | 2016 | 4729 | 0.020 |
Why?
|
| Hypospadias | 1 | 2011 | 98 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2019 | 2573 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15401 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 714 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2023 | 5987 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2010 | 205 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2013 | 1984 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3225 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 2844 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 2662 | 0.020 |
Why?
|
| Organogenesis | 1 | 2011 | 213 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 26282 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2020 | 4023 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5880 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4882 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2925 | 0.020 |
Why?
|
| Injections | 1 | 2012 | 839 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2013 | 2270 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 353 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 1014 | 0.020 |
Why?
|
| Nuclear Family | 1 | 2009 | 311 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 22340 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 2011 | 573 | 0.020 |
Why?
|
| Peptides | 1 | 2020 | 4331 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2081 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 868 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2017 | 1338 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2017 | 2502 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2013 | 1005 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1331 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3684 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1366 | 0.020 |
Why?
|
| Tyrosine | 1 | 2012 | 1427 | 0.020 |
Why?
|
| Electromyography | 1 | 2013 | 1398 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1150 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2008 | 202 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 59496 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 1527 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6503 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2267 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2676 | 0.020 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2006 | 23 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10575 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20690 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4641 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 3089 | 0.010 |
Why?
|
| Ureter | 1 | 2007 | 364 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9541 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 1194 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6542 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2011 | 2089 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3530 | 0.010 |
Why?
|
| Algorithms | 1 | 2023 | 14064 | 0.010 |
Why?
|
| Time Factors | 2 | 2016 | 40097 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11196 | 0.010 |
Why?
|
| Histones | 1 | 2013 | 2590 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 8107 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5784 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 8060 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9373 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2012 | 8530 | 0.010 |
Why?
|
| Proteomics | 1 | 2010 | 3906 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3678 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2009 | 9351 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 4246 | 0.010 |
Why?
|
| United States | 1 | 2019 | 72909 | 0.010 |
Why?
|